Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
Why the future of marijuana legalization remains hazy despite high public support 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
One of the biggest challenges that doctors and scientists are faced with today is developing a cure for the deadly virus known as HIV or AIDS. Having become prevalent for decades, responsible for taking millions of lives, everyone is on the search for a cure, and patients are willing to risk their lives to make it happen.
As the HIV/AIDS epidemic rages on, there has been some progress made towards developing a cure to the deadly disease over recent years. A new study on the disease, titled “HIV Cure Research,” revealed that a portion of people who are HIV-positive are willing to risk their lives in the clinical trials. To them, they are willing to risk near-certain death if it means helping in developing a cure. According to a patient that was interviewed, “I’m not going to live forever… It is about the next man, the next woman, and you have to have the mindset to care about people, which I do.”
Another patient that was also interviewed explained that they are willing to go this far for the community living with the disease. They expressed their hope at how much of a game-changer it would be to see a cure made.
On the other hand, the authors of the study explained that if HIV-positive patients are allowed to volunteer for the experiments, they said that there should be ethical safeguards placed. This is to ensure that patients have a say in their involvement in research that has the possibility to be fatal for them.
Everyone is putting a united front in battling the disease to put a stop to the epidemic once and for all. Scientists from the University of Nebraska Medical Center and Temple University were able to come up with a kind of therapy that cured the virus of living animals. This was the biggest breakthrough towards the journey for the cure to HIV/AIDS, and the future is bright for the cure for humans.
According to Dr. Howard Gendelman of the University of Nebraska, they are moving closer to making human trials for the type of therapy that could potentially cure HIV/AIDS. Referred to as LASER-ART - which is a slow-effect release antiretroviral therapy, with a few more tests and experiments, it could be ready for human trials within the upcoming year or two.
